Home › Smoldering Multiple Myeloma › Georgia › Atlanta
Smoldering Multiple Myeloma clinical trials in Atlanta, GA
5 studies for Smoldering Multiple Myeloma are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
RecruitingPhase 3
- Emory University - Winship Cancer Institute, Atlanta
A Study of JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma
RecruitingPhase 1
- Winship Cancer Institute Emory University, Atlanta
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
RecruitingPhase 3
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
RecruitingPhase 2
- Emory University Hospital/Winship Cancer Institute, Atlanta
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Recruiting
- Emory University (Data Collection Only), Atlanta
Smoldering Multiple Myeloma trials in other cities
- Boston, MA6 studies
- New York City, NY6 studies
- Denver, CO3 studies
- Salt Lake City, UT3 studies
- Durham, NC3 studies
- Columbus, OH3 studies
- Edison, NJ3 studies
- Houston, TX3 studies
Other studies in Atlanta
- Cancer (all types)50 studies
- Non-Small Cell Lung Cancer46 studies
- Breast Cancer41 studies
- Multiple Myeloma41 studies
- Prostate Cancer32 studies
- Colorectal Cancer29 studies
- Lung Cancer29 studies
- Ovarian Cancer28 studies
- Acute Myeloid Leukemia28 studies
- Obesity27 studies
- Metastatic Cancer27 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.